Form 4: Twist Bioscience CEO Emily Leproust Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Emily Leproust sold shares of Twist Bioscience to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On October 2, 2024, Emily M. Leproust, CEO of Twist Bioscience Corp, sold 13,605 shares of common stock at a price of $43.211 per share.
- The sale was mandated by the Issuer's election under its equity incentive plans to cover tax withholding obligations related to the vesting of Restricted Stock Units.
- Following the transaction, Leproust directly owns 481,918 shares of Twist Bioscience.
- Leproust also holds various employee stock options with different exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (stock sale for tax obligations). It's neutral in sentiment as it doesn't indicate any significant positive or negative developments for the company.
Industry Context
This is a routine Form 4 filing, reflecting the sale of shares by a company executive to cover tax obligations. Such transactions are common and generally don't indicate a change in the executive's long-term outlook on the company.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are a common practice across publicly traded companies, including those in the biotechnology sector like Illumina, Agilent, and Thermo Fisher Scientific.
- The size of the sale (13,605 shares) is relatively small compared to the total holdings of the CEO (481,918 shares), suggesting it's a routine transaction rather than a significant divestment.
Stakeholder Impact
- The sale of shares may have a minor, temporary impact on the stock price, but it's unlikely to significantly affect long-term shareholders.
- Employees holding stock options or RSUs may be interested in the transaction as it relates to their own tax obligations.
Key Dates
| Date | Description |
|---|---|
| 12/19/2022 | Performance stock options granted on September 1, 2020, vested and became exercisable. |
| 09/28/2025 | Expiration date for employee stock options with an exercise price of $5.95. |
| 09/28/2027 | Expiration date for employee stock options with an exercise price of $8.82. |
| 11/18/2028 | Expiration date for employee stock options with an exercise price of $26.66. |
| 10/23/2029 | Expiration date for employee stock options with an exercise price of $23.33. |
| 08/31/2030 | Expiration date for employee stock options with an exercise price of $67.85. |
| 10/02/2024 | Emily Leproust sold 13,605 shares of Twist Bioscience common stock. |
| 10/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.